Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Gynecologic Oncology|February 26, 2026
Rectosigmoidectomy versus pelvic peritonectomy in the management of seromuscular involvement of superficial rectal wall tumors in advanced-stage ovarian cancer at complete interval cytoreductive surgeryA Rafael Guijarro-Campillo, Alida González-Gil, Elena Gil-Gómez, et al.
Cancers|March 14, 2026
Neoadjuvant Chemotherapy Following Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Retrospective Cohort StudyAlberto Rafael Guijarro-Campillo, Alida González-Gil, Elena Gil-Gómez, et al.
Clinical & Experimental Metastasis|July 5, 2019
Peritoneal Surface Disease Severity Score (PSDSS), AGO-score and TIAN model in patients with platinum-sensitive recurrent ovarian cancer treated by cytoreductive surgery plus HIPECÁlvaro Jesús Gómez-Ruiz, Alida González-Gil, José Gil, et al.
Cancers|June 26, 2025
Combined Hyperthermic Intraperitoneal Chemotherapy and Normothermic Intraperitoneal Chemotherapy Long-Term After Interval Cytoreduction in Ovarian Cancer: A Phase I Clinical Trial (BICOV1)Alida González-Gil, Elena Gil-Gómez, Vicente Olivares-Ripoll, et al.
Langenbeck'S Archives of Surgery|July 20, 2021
Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent usedÁlvaro Jesús Gómez-Ruiz, Alida González-Gil, José Gil, et al.
Cancers|July 14, 2023
HIPEC in Ovarian Cancer Is the Future… and Always Will Be? Results from a Spanish Multicentric SurveyAlida González Gil, Álvaro Cerezuela Fernández-de Palencia, Álvaro Jesús Gómez Ruiz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 5, 2026
The myth of eradicating peritoneal surface malignancies: How ultramicroscopic disease undermines the potential benefits of hyperthermic intraperitoneal chemotherapyRubén Corral-San Miguel, Alida González-Gil, Antonia Tomás-Loba, et al.
World Journal of Surgical Oncology|February 1, 2025
Textbook outcome in ovarian cancer and its impact on survival: comparative studySilvia Carbonell-Morote, Alvaro Arjona-Sánchez, Pedro Antonio Cascales-Campos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 11, 2022
Interval cytoredutive surgery and HIPEC in advanced ovarian cancer with small-bowel disease: results and reflectionsPedro Antonio Cascales Campos, Alida González Gil, Álvaro Jesús Gómez Ruiz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 4, 2026
Futility in patients with peritoneal carcinomatosis of ovarian origin undergoing or who underwent interval cytoreductive surgery: a multicenter retrospective observational studySilvia Carbonell-Morote, Alvaro Arjona-Sánchez, Pedro Antonio Cascales-Campos, et al.
Pageof 2